Crane Rosemary A
Insider CIK 1443343 · MELA CEO and President, Director · EDGE Director · CTLT Director · TARS Director · CERT Director · TEVA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2026-06-05 | 2026-06-08 | 14,492 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2026-06-05 | 2026-06-08 | 14,492 | — | $0 | 127,739 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2026-05-28 | 2026-06-01 | 7,242 | — | $0 | 7,242 | SEC↗ |
| CERT Certara, Inc. | M Exercise deriv | 2026-05-14 | 2026-05-15 | 15,757 | — | $0 | 0 | SEC↗ |
| CERT Certara, Inc. | M Exercise | 2026-05-14 | 2026-05-15 | 15,757 | — | $0 | 45,672 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2025-06-06 | 2025-06-09 | 9,632 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2025-06-06 | 2025-06-09 | 9,632 | — | $0 | 113,247 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2025-06-05 | 2025-06-09 | 14,492 | — | $0 | 14,492 | SEC↗ |
| CERT Certara, Inc. | A Award deriv | 2025-05-21 | 2025-05-22 | 15,757 | — | $0 | 15,757 | SEC↗ |
| CERT Certara, Inc. | M Exercise deriv | 2025-05-21 | 2025-05-22 | 11,928 | — | $0 | 0 | SEC↗ |
| CERT Certara, Inc. | M Exercise | 2025-05-21 | 2025-05-22 | 11,928 | — | $0 | 29,915 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2024-06-24 | 2024-06-25 | 3,350 | — | $0 | 0 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise | 2024-06-24 | 2024-06-25 | 3,350 | — | $0 | 5,350 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2024-06-15 | 2024-06-17 | 21,108 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2024-06-15 | 2024-06-17 | 21,108 | — | $0 | 103,615 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2024-06-13 | 2024-06-14 | 3,350 | — | $0 | 3,350 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2024-06-13 | 2024-06-14 | 5,000 | — | $0 | 5,000 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2024-06-06 | 2024-06-10 | 9,632 | — | $0 | 9,632 | SEC↗ |
| CERT Certara, Inc. | M Exercise deriv | 2024-05-21 | 2024-05-23 | 8,663 | — | $0 | 0 | SEC↗ |
| CERT Certara, Inc. | A Award deriv | 2024-05-21 | 2024-05-23 | 11,928 | — | $0 | 11,928 | SEC↗ |
| CERT Certara, Inc. | M Exercise | 2024-05-21 | 2024-05-23 | 8,663 | — | $0 | 17,987 | SEC↗ |
| CTLT Catalent, Inc. | A Award | 2023-10-27 | 2023-10-31 | 6,993 | — | $0 | 23,873 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2023-08-04 | 2023-08-07 | 15,810 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2023-08-04 | 2023-08-07 | 15,810 | — | $0 | 82,507 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2023-06-22 | 2023-06-26 | 3,350 | — | $0 | 3,350 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2023-06-22 | 2023-06-26 | 5,000 | — | $0 | 5,000 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2023-06-16 | 2023-06-21 | 2,000 | — | $0 | 0 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise | 2023-06-16 | 2023-06-21 | 2,000 | — | $0 | 2,000 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2023-06-15 | 2023-06-20 | 21,108 | — | $0 | 21,108 | SEC↗ |
| CERT Certara, Inc. | M Exercise deriv | 2023-05-23 | 2023-05-25 | 9,324 | — | $0 | 0 | SEC↗ |
| CERT Certara, Inc. | A Award deriv | 2023-05-23 | 2023-05-25 | 8,663 | — | $0 | 8,663 | SEC↗ |
| CERT Certara, Inc. | M Exercise | 2023-05-23 | 2023-05-25 | 9,324 | — | $0 | 9,324 | SEC↗ |
| CTLT Catalent, Inc. | A Award | 2022-10-27 | 2022-10-31 | 4,149 | — | $0 | 16,880 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2022-08-04 | 2022-08-08 | 15,810 | — | $0 | 15,810 | SEC↗ |
| CERT Certara, Inc. | A Award deriv | 2022-07-21 | 2022-07-22 | 9,324 | — | $0 | 9,324 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2022-06-16 | 2022-07-01 | 7,000 | — | $0 | 7,000 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2022-06-16 | 2022-07-01 | 2,000 | — | $0 | 2,000 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2022-06-14 | 2022-06-16 | 14,479 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2022-06-14 | 2022-06-16 | 14,479 | — | $0 | 66,697 | SEC↗ |
| CTLT Catalent, Inc. | A Award | 2021-10-28 | 2021-11-01 | 1,402 | — | $0 | 12,731 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2021-08-11 | 2021-08-12 | 20,000 | — | $0 | 20,000 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2021-06-14 | 2021-06-16 | 14,479 | — | $0 | 14,479 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2021-06-09 | 2021-06-10 | 12,668 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2021-06-09 | 2021-06-10 | 12,668 | — | $0 | 52,218 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2021-06-05 | 2021-06-08 | 6,041 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2021-06-05 | 2021-06-08 | 6,041 | — | $0 | 39,550 | SEC↗ |
| CTLT Catalent, Inc. | A Award | 2020-10-29 | 2020-11-02 | 2,125 | — | $0 | 11,329 | SEC↗ |
| CTLT Catalent, Inc. | A Award | 2020-08-27 | 2020-08-28 | 661 | — | $0 | 9,204 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2020-08-11 | 2020-08-13 | 7,956 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2020-08-11 | 2020-08-13 | 2,860 | $11.90 | $34.0K | 33,509 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2020-08-11 | 2020-08-13 | 7,956 | — | $0 | 36,369 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2020-06-11 | 2020-06-15 | 17,621 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2020-06-11 | 2020-06-15 | 17,621 | — | $0 | 28,413 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2020-06-09 | 2020-06-11 | 12,668 | — | $0 | 12,668 | SEC↗ |
| CTLT Catalent, Inc. | A Award | 2019-08-22 | 2019-08-26 | 3,167 | — | $0 | 8,543 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2019-06-11 | 2019-06-13 | 17,621 | — | $0 | 17,621 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2019-05-16 | 2019-05-20 | 2,780 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2019-05-16 | 2019-05-20 | 2,780 | — | $0 | 10,792 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | M Exercise deriv | 2019-03-15 | 2019-03-18 | 10,000 | — | $0 | 0 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | M Exercise | 2019-03-15 | 2019-03-18 | 10,000 | — | $0 | 10,000 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2018-09-03 | 2018-09-05 | 2,162 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2018-09-03 | 2018-09-05 | 2,162 | — | $0 | 8,012 | SEC↗ |
| CTLT Catalent, Inc. | A Award | 2018-08-23 | 2018-08-24 | 4,183 | — | $0 | 5,376 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | A Award deriv | 2018-08-14 | 2018-08-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | A Award deriv | 2018-06-19 | 2018-06-20 | 20,000 | — | $0 | 20,000 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2018-06-05 | 2018-06-07 | 6,041 | — | $0 | 6,041 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | A Award deriv | 2017-09-18 | 2017-09-20 | 30,000 | — | $0 | 30,000 | SEC↗ |
| MELA MELA SCIENCES, INC. /NY | P Buy | 2014-02-05 | 2014-02-06 | 67,570 | $0.74 | $50.0K | 67,570 | SEC↗ |
| MELA MELA SCIENCES, INC. /NY | A Award deriv | 2013-11-11 | 2013-11-13 | 400,000 | — | $0 | 400,000 | SEC↗ |